These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37421203)
1. The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3/cyclin D1 pathway. Meng H; Li J; Sun H; Lin Y; Xu H; Zhang N Drug Dev Res; 2023 Sep; 84(6):1325-1334. PubMed ID: 37421203 [TBL] [Abstract][Full Text] [Related]
2. Transcription factor RELA promotes hepatocellular carcinoma progression by promoting the transcription of m6A modulator METTL3. Wu J; Wang W; Zheng Y; Deng W; Liu J Pathol Res Pract; 2024 Mar; 255():155168. PubMed ID: 38367599 [TBL] [Abstract][Full Text] [Related]
3. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1. Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264 [TBL] [Abstract][Full Text] [Related]
4. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling. Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939 [TBL] [Abstract][Full Text] [Related]
5. Amentoflavone attenuates cell proliferation and induces ferroptosis in human gastric cancer by miR-496/ATF2 axis. Tang F; Xu Y; Gao E; Zhang W; Zhang F; Xiang Y; Xu L; Dong F Chem Biol Drug Des; 2023 Oct; 102(4):782-792. PubMed ID: 37455326 [TBL] [Abstract][Full Text] [Related]
6. Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway. Zhang X; Zhang Y; Fan C; Wang L; Liu Y; Li A; Jiang G; Zhou H; Cai L; Miao Y Tumour Biol; 2017 Jun; 39(6):1010428317705515. PubMed ID: 28618963 [TBL] [Abstract][Full Text] [Related]
7. METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer. Wang XK; Zhang YW; Wang CM; Li B; Zhang TZ; Zhou WJ; Cheng LJ; Huo MY; Zhang CH; He YL J Cell Mol Med; 2021 Jul; 25(14):6602-6617. PubMed ID: 34075693 [TBL] [Abstract][Full Text] [Related]
8. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis. Song C; Zhou C J Exp Clin Cancer Res; 2021 Feb; 40(1):62. PubMed ID: 33563300 [TBL] [Abstract][Full Text] [Related]
9. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471 [TBL] [Abstract][Full Text] [Related]
10. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related]
11. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2. Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970 [TBL] [Abstract][Full Text] [Related]
12. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway. Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425 [TBL] [Abstract][Full Text] [Related]
13. Regulation of the Gu P; Huang W; Lu W; Shu P Discov Med; 2024 May; 36(184):923-935. PubMed ID: 38798252 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of miR-204 regulates proliferation, apoptosis and autophagy of cervical cancer cells by targeting ATF2. Li N; Guo X; Liu L; Wang L; Cheng R Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2529-2535. PubMed ID: 31204513 [No Abstract] [Full Text] [Related]
15. m Liu Y; Zhai E; Chen J; Qian Y; Zhao R; Ma Y; Liu J; Huang Z; Cai S; Chen J Cancer Commun (Lond); 2022 Apr; 42(4):327-344. PubMed ID: 35261206 [TBL] [Abstract][Full Text] [Related]
16. miR-638 suppresses cell proliferation in gastric cancer by targeting Sp2. Zhao LY; Yao Y; Han J; Yang J; Wang XF; Tong DD; Song TS; Huang C; Shao Y Dig Dis Sci; 2014 Aug; 59(8):1743-53. PubMed ID: 24623314 [TBL] [Abstract][Full Text] [Related]
17. METTL3-mediated m Ji G; Wang X; Xi H Int J Immunopathol Pharmacol; 2023; 37():3946320231204694. PubMed ID: 37823387 [TBL] [Abstract][Full Text] [Related]
18. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m He H; Wu W; Sun Z; Chai L Biochem Biophys Res Commun; 2019 Oct; 517(4):581-587. PubMed ID: 31395342 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1269 promotes cell proliferation via the AKT signaling pathway by targeting RASSF9 in human gastric cancer. Liu WL; Wang HX; Shi CX; Shi FY; Zhao LY; Zhao W; Wang GH Cancer Cell Int; 2019; 19():308. PubMed ID: 31768130 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression. Kang J; Huang X; Dong W; Zhu X; Li M; Cui N Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]